LCD L39467: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — Noridian
Policy LCD-L39467 · Rheumatology
New billing guidance for biomarker testing in RA effective 2026.
Code intelligence
M06.02 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code M06.02.
Elevated code riskView ICD-10 detail
Signal breakdown
1 shown · 1 total in platform
Risk: Elevated
0
Critical
0%
1
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
Audit documentation
Building an audit file that includes M06.02?
The Tripwire Audit Pack exports 12 months of Rheumatology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Rheumatology audit pack — $349One-time purchase · not a subscription